Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Patterson

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Depression and Anxiety|September 24, 2005
Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case seriesMichael Van Ameringen, Catherine Mancini, Beth Patterson, et al.
CNS Neuroscience & Therapeutics|September 20, 2008
Post-traumatic stress disorder in CanadaMichael Van Ameringen, Catherine Mancini, Beth Patterson, et al.
Journal of Psychiatric Research|September 2, 2016
The use of waitlists as control conditions in anxiety disorders researchBeth Patterson, Michael H Boyle, Michelle Kivlenieks, et al.
CNS Neuroscience & Therapeutics|April 27, 2010
The prevalence of migraine headaches in an anxiety disorders clinic sampleRhandi Senaratne, Michael Van Ameringen, Catherine Mancini, et al.
Depression and Anxiety|June 5, 2009
Trichotillomania in youth: a retrospective case seriesCatherine Mancini, Michael Van Ameringen, Beth Patterson, et al.
Journal of Child and Adolescent Psychopharmacology|September 30, 2005
Emerging treatments for child and adolescent social phobia: a reviewCatherine Mancini, Michael Van Ameringen, Mark Bennett, et al.
Journal of Psychiatric Research|February 11, 2019
Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis usersJasmine Turna, William Simpson, Beth Patterson, et al.
Journal of Psychiatric Research|November 29, 2025
New treatments for OCD? Evidence for cannabinoids and psychedelicsMichael Van Ameringen, Vidhi Patel, Beth Patterson, et al.
Journal of the International Neuropsychological Society : JINS|November 2, 2011
Physical activity associated with increased resting-state functional connectivity in multiple sclerosisRuchika Shaurya Prakash, Beth Patterson, Alisha Janssen, et al.
The Journal of Clinical Psychiatry|May 6, 2010
A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomaniaMichael Van Ameringen, Catherine Mancini, Beth Patterson, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Depression and Anxiety|September 24, 2005
Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case seriesMichael Van Ameringen, Catherine Mancini, Beth Patterson, et al.
CNS Neuroscience & Therapeutics|September 20, 2008
Post-traumatic stress disorder in CanadaMichael Van Ameringen, Catherine Mancini, Beth Patterson, et al.
Journal of Psychiatric Research|September 2, 2016
The use of waitlists as control conditions in anxiety disorders researchBeth Patterson, Michael H Boyle, Michelle Kivlenieks, et al.
CNS Neuroscience & Therapeutics|April 27, 2010
The prevalence of migraine headaches in an anxiety disorders clinic sampleRhandi Senaratne, Michael Van Ameringen, Catherine Mancini, et al.
Depression and Anxiety|June 5, 2009
Trichotillomania in youth: a retrospective case seriesCatherine Mancini, Michael Van Ameringen, Beth Patterson, et al.
Journal of Child and Adolescent Psychopharmacology|September 30, 2005
Emerging treatments for child and adolescent social phobia: a reviewCatherine Mancini, Michael Van Ameringen, Mark Bennett, et al.
Journal of Psychiatric Research|February 11, 2019
Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis usersJasmine Turna, William Simpson, Beth Patterson, et al.
Journal of Psychiatric Research|November 29, 2025
New treatments for OCD? Evidence for cannabinoids and psychedelicsMichael Van Ameringen, Vidhi Patel, Beth Patterson, et al.
Journal of the International Neuropsychological Society : JINS|November 2, 2011
Physical activity associated with increased resting-state functional connectivity in multiple sclerosisRuchika Shaurya Prakash, Beth Patterson, Alisha Janssen, et al.
The Journal of Clinical Psychiatry|May 6, 2010
A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomaniaMichael Van Ameringen, Catherine Mancini, Beth Patterson, et al.
Pageof 5